| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |